These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30053223)

  • 1. Characteristics and factors associated with treatment delay in pleural tuberculosis.
    Zhang W; Han C; Wang MS; He Y
    QJM; 2018 Nov; 111(11):779-783. PubMed ID: 30053223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for tuberculous empyema in pleural tuberculosis patients.
    Wen P; Wei M; Han C; He Y; Wang MS
    Sci Rep; 2019 Dec; 9(1):19569. PubMed ID: 31863026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment delay in childhood pleural tuberculosis and associated factors.
    Gong HZ; Han C; Yang FL; Wang CF; Wang JL; Wang MS
    BMC Infect Dis; 2020 Oct; 20(1):793. PubMed ID: 33109109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of drug resistance among patients with tuberculous pleural effusion in Greece.
    Anastasakos V; Skouras V; Moschos C; Tsikrika S; Karabela S; Marinou I; Vogiatzakis E; Konstantinou K; Papavasiliou A; Kalomenidis I
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):309-313. PubMed ID: 28225341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleural tuberculosis: A concise clinical review.
    Shaw JA; Irusen EM; Diacon AH; Koegelenberg CF
    Clin Respir J; 2018 May; 12(5):1779-1786. PubMed ID: 29660258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Multidrug-Resistant Tuberculosis among Patients with Pulmonary Tuberculosis at the Central Chest Institute of Thailand.
    Chuchottaworn C; Thanachartwet V; Sangsayunh P; Than TZ; Sahassananda D; Surabotsophon M; Desakorn V
    PLoS One; 2015; 10(10):e0139986. PubMed ID: 26444421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for diagnosis and treatment delay among patients with multidrug-resistant tuberculosis in Hunan Province, China.
    Akalu TY; Clements ACA; Gebreyohannes EA; Xu Z; Bai L; Alene KA
    BMC Infect Dis; 2024 Feb; 24(1):159. PubMed ID: 38308252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance in patients with tuberculous pleural effusions.
    Skouras VS; Kalomenidis I
    Curr Opin Pulm Med; 2018 Jul; 24(4):374-379. PubMed ID: 29528853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of T-SPOT.TB for the diagnosis of unconventional pleural tuberculosis is superior to ADA in high prevalence areas: a prospective analysis of 601 cases.
    Yang X; Zhang J; Liang Q; Pan L; Duan H; Yang Y; Li H; Guo C; Sun Q; Jia H; Du B; Wei R; Xing A; Zhang Z; Chen X
    BMC Infect Dis; 2021 Jan; 21(1):4. PubMed ID: 33397312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic methods of primary tuberculous pleural effusion in a region with high prevalence of tuberculosis. A study in Mexican population.
    Salazar-Lezama M; Quiroz-Rosales H; Bañales-Méndez JL; Sánchez-Guzmán M; Villarreal-Velarde H; Báez-Saldaña R; Azcona-Martínez E; Selman-Lama M
    Rev Invest Clin; 1997; 49(6):453-6. PubMed ID: 9580281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study.
    Alene KA; Viney K; McBryde ES; Gray DJ; Melku M; Clements ACA
    Transbound Emerg Dis; 2019 Jul; 66(4):1611-1618. PubMed ID: 30924283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography features of extensively drug-resistant pulmonary tuberculosis in non-HIV-infected patients.
    Lee ES; Park CM; Goo JM; Yim JJ; Kim HR; Lee HJ; Lee IS; Im JG
    J Comput Assist Tomogr; 2010 Jul; 34(4):559-63. PubMed ID: 20657225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
    Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
    Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis.
    Xi Y; Zhang W; Qiao RJ; Tang J
    PLoS One; 2022; 17(6):e0270003. PubMed ID: 35709161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey.
    Kamolwat P; Nateniyom S; Chaiprasert A; Disratthakit A; Mahasirimongkol S; Yamada N; Smithtikarn S
    Trop Med Int Health; 2021 Jan; 26(1):45-53. PubMed ID: 32997863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors of multidrug-resistant tuberculosis in Cubal, Angola: a prospective cohort study.
    Aznar ML; Rando-Segura A; Moreno MM; Soley ME; Igual ES; Bocanegra C; Olivas EG; Eugénio AN; Zacarias A; Katimba D; Gabriel E; Mendioroz J; García MTL; Suñe TP; Fernández MTT; Romero IM
    Int J Tuberc Lung Dis; 2019 Jan; 23(1):67-72. PubMed ID: 30674377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delays in care seeking, diagnosis and treatment among pulmonary tuberculosis patients in Shenzhen, China.
    Xu X; Liu JH; Cao SY; Zhao Y; Dong XX; Liang Y; Lu ZX
    Int J Tuberc Lung Dis; 2013 May; 17(5):615-20. PubMed ID: 23575326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors.
    Xu C; Li R; Shewade HD; Jeyashree K; Ruan Y; Zhang C; Wang L; Zhang H
    PLoS One; 2019; 14(4):e0214943. PubMed ID: 30958841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.